Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allenge India is an Indian commercial-stage pharmaceutical company focused on developing, marketing, and supplying a broad portfolio of affordable branded pharma products. The company presents itself as a marketing-led pharma business with third-party manufacturing capabilities and PCD/franchise distribution, offering products across major therapeutic categories including cardiology, diabetes care, nephrology, anti-inflammatory, skin care, gynecology, vitamins, respiratory, gastrointestinal, and CNS. Its website indicates a large marketed portfolio, with product listings spanning roughly 170+ SKUs and broader claims of 500+ products, and states that products are manufactured in WHO-GMP accredited facilities. The company appears to operate from Panchkula, Haryana, and positions itself as an ISO 9001:2015-certified pharma supplier serving India and some global markets through branded generics and distribution partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allenge India Pharma.